Hosted on MSN

China’s drugs offer lifeline for global pharma as it peers over the patent cliff

Out-licensing of clinical candidates from China has increased dramatically over the last five years, as the world’s pharma companies shore up their pipelines in anticipation of an approaching patent ...
Washington Examiner

Chinese vape imports surge despite Trump administration’s crackdown, data suggests

In June, President Donald Trump’s effort to reduce the number of Chinese vapes entering the United States appeared to be progressing well. Chinese export data showed that in April, the month Trump’s ...
The Manila Times

Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor

Based on the positive global Phase III MANEUVER study, the National Medical Products Administration (NMPA) has granted the ...